semaglutide fda shortage list is still on the As of February 21, 2025, updated its drug fda declares semaglutide shortage over

For example, long-acting amylin analogues are in various stages of clinical development (Cagrilintide, Novo Nordisk

It is built around how that formula is delivered

GLP-1RAs and CVOTs Available GLP-1RAs (except for exenatide twice daily) have been examined in multicentre, double-blinded, randomised, placebo-controlled cardiovascular (CV) outcomes trials (CVOTs)

Therefore, even samples where the labeled API was confirmed may not be consistent with the declaration because of variations in API concentrations, which may have health implications for consumers

Research suggests that this is even more important for women who are pregnant or lactating (6)